Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'21
Sep'21
Sep'20
Net Sales
103.30
66.81
49.86
Other Operating Income
0.00
0.00
0.00
Total Operating income
103.30
66.81
49.86
Raw Material Cost
25.57
23.06
13.93
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.19
0.21
4.59
Selling and Distribution Expenses
11.34
17.45
5.41
Other Expenses
0.57
0.22
-0.27
Total Expenditure (Excl Depreciation)
42.85
42.92
21.23
Operating Profit (PBDIT) excl Other Income
60.4
23.900000000000002
28.599999999999998
Other Income
3.45
3.65
0.68
Operating Profit (PBDIT)
67.55
30.92
33.26
Interest
0.19
0.21
4.59
Exceptional Items
-25.38
0.38
0.11
Gross Profit (PBDT)
77.73
43.76
35.93
Depreciation
4.23
4.17
3.93
Profit Before Tax
54.15
10.76
24.85
Tax
8.59
3.17
4.63
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
45.55
7.59
20.22
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
45.55
7.59
20.22
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.55
7.59
20.22
Equity Capital
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
Reserves
849.55
791.59
0.00
Earnings per share (EPS)
0.23
0.04
0.0
Diluted Earnings per share
0.23
0.04
0.0
Operating Profit Margin (Excl OI)
57.96%
34.58%
57.45%
Gross Profit Margin
56.51%
22.35%
57.72%
PAT Margin
44.1%
11.36%
40.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Analysis not available
Compare Quarterly Results Of Mega Genomics Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
103.30
0.00
103.30
Other Operating Income
0.00
0.00
0.00
Total Operating income
103.30
0.00
103.30
Raw Material Cost
25.57
0.00
25.57
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.19
0
0.19
Selling and Distribution Expenses
11.34
0.08
11.26
14,075.00%
Other Expenses
0.57
0.00
0.57
Total Expenditure (Excl Depreciation)
42.85
0.08
42.77
53,462.50%
Operating Profit (PBDIT) excl Other Income
60.45
-0.08
60.53
75,662.50%
Other Income
3.45
-0.20
3.65
1,825.00%
Operating Profit (PBDIT)
67.55
-0.08
67.63
84,537.50%
Interest
0.19
0.08
0.11
137.50%
Exceptional Items
-25.38
0
-25.38
Gross Profit (PBDT)
77.73
-0.00
77.73
Depreciation
4.23
0.00
4.23
Profit Before Tax
54.15
-0.36
54.51
15,141.67%
Tax
8.59
0.00
8.59
Provisions and contingencies
0.00
0
0.00
Profit After Tax
45.55
-0.36
45.91
12,752.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
45.55
-0.36
45.91
12,752.78%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.55
-0.36
45.91
12,752.78%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
849.55
2.68
846.87
31,599.63%
Earnings per share (EPS)
0.23
-0.01
0.24
2,400.00%
Diluted Earnings per share
0.23
-0.01
0.24
2,400.00%
Operating Profit Margin (Excl OI)
57.96%
0%
0.00
57.96%
Gross Profit Margin
56.51%
0%
0.00
56.51%
PAT Margin
44.10%
0%
0.00
44.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in Figures in Million
Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in Figures in Million
Quarterly - Interest
Interest NA Million
in Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
